Congress orders overdose research—but won't fund hospitals to act on it
S. 921 — Tyler’s Law · Filed by Jim Banks (R-IN) · 13 cosponsors · Introduced Mar 10, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to study how often hospital emergency departments test for fentanyl when patients arrive with overdoses, what barriers exist, and what the costs and benefits are—then issue guidance within 9 months of completing the study on whether hospitals should make fentanyl testing routine for overdose patients. The bill does not mandate testing; it requires research and recommendations.
Why we flagged it
The bill's operative mechanism is a study and guidance issuance—standard public health policy development. It does not create new programs, spending, or mandates; it directs HHS to investigate and advise on fentanyl testing in emergency departments.
What the text implies
- Guidance (not mandate) means hospitals retain discretion; implementation will vary by region and resource availability, potentially widening disparities in overdose care.
- Study must examine privacy/security under HIPAA; findings may reveal tension between testing utility and patient confidentiality concerns in overdose cases.
The full analysis lists 3 implications of this text.
Who stands to gain
diagnostic testing companies; hospital systems (if testing becomes standard)